{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Trial Talk","title":"Episode 1: Careers in TB trials with Andrew Nunn and Sarah Meredith","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/4b4a1107\"></iframe>","width":"100%","height":180,"duration":1737,"description":"In the first episode of our new Trial Talk series, Hanif Esmail and Conor Tweed take over the microphones to interview Andrew Nunn and Sarah Meredith, who have both recently retired from the Unit, having spent a combined total of 92 years working in the field of tuberculosis (TB). As we celebrate Andrew and Sarah’s long and accomplished careers, we’ll dive into the history of TB clinical trials and muse on the future of TB research.\nFor more information and to access the transcript: https://www.mrcctu.ucl.ac.uk/news/news-stories/2024/january/new-podcast-episode-careers-in-tb-clinical-trials \nCheck out our earlier podcast episodes about TB trials, also featuring Andrew Nunn:\n• Trial-talk-podcast – The-stream2-trial-how-should-we-treat-multi-drug-resistant-tuberculosis\n• Trial-talk-podcast – Andrew-nunn-talks-medical-statistics-tb-and-algerian-nomads-part-1\n• Trial-talk-podcast – Andrew-nunn-talks-medical-statistics-tb-and-algerian-nomads-part-2\n\nFor questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk\n\nAs a listener, your opinion is very valuable to us. Please help us to improve the podcast in the future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g\n\n Date of episode recording: 2024-01-26T00:00:00Z\n Duration: 28:56\n Language of episode: English \n Presenters: Charlotte Hartley, Hanif Esmail, Conor Tweed\n Guests: Andrew Nunn, Sarah Meredith\n Producer: Charlotte Hartley\n \nThe Trial Talk podcast explores how our work at the MRC Clinical Trials Unit at UCL is improving health in the UK and worldwide. In this new series, we will hear from world-leading experts about the studies we carry out. We delve into trials on cancer, infections, and neurodegenerative diseases, explore how public and patient involvement shapes our work, and discover new ways to run smarter studies.","thumbnail_url":"https://img.transistorcdn.com/_Gs61f_CYn4elE1E_qmem3ay3JqZHcF-BnvFPSYiuWI/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wNjkz/NGQyMDRlMjRkNDcw/MGU1MTNiN2I4NDkw/MTYzYi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}